The HLA-DRβ16 allogenotype constitutes a risk factor for hypertrophic scarring
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Human Immunology
- Vol. 29 (3), 229-232
- https://doi.org/10.1016/0198-8859(90)90117-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Anomalous expression of HLA class II molecules on keratinocytes and fibroblasts in hypertrophic scars consequent to thermal injuryClinical and Experimental Immunology, 1990
- Differential Regulation of Collagen, Glycosaminoglycan, Fibronectin, and Collagenase Activity Production in Cultured Human Adult Dermal Fibroblasts by Interleukin 1-Alpha and Beta and Tumor Necrosis Factor-Alpha and Beta.Journal of Investigative Dermatology, 1989
- DNA-RFLP analysis and genotyping of HLA-DR and DQ antigensImmunology Today, 1988
- Association between HLA‐DR2 and Production of Tumour Necrosis Factor α and Interleukin 1 by Mononuclear Cells Activated by LipopolysaccharideScandinavian Journal of Immunology, 1988
- Some observations on the surface structure of collagen in hypertrophic scarsBurns, 1985
- General Immune Reactivity in Keloid PatientsPlastic and Reconstructive Surgery, 1984
- Studies on the immunologic aspects of keloids and hypertrophic scarsArchives of Dermatological Research, 1982
- Association of psoriasis with HLA-DR7British Journal of Dermatology, 1982
- Immunoglobulin, Complement, and Histocompatibility Antigen Studies in Keloid PatientsPlastic and Reconstructive Surgery, 1979
- HYPERTROPHIC SCARS AND KELOIDS A Collective ReviewPlastic and Reconstructive Surgery, 1974